News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,204 Results
Type
Article (14065)
Company Profile (304)
Press Release (248835)
Section
Business (79501)
Career Advice (152)
Deals (13226)
Drug Delivery (34)
Drug Development (50436)
Employer Resources (31)
FDA (5706)
Job Trends (5128)
News (144451)
Policy (10097)
Tag
Academia (901)
Alliances (21605)
Alzheimer's disease (778)
Antibody-drug conjugate (ADC) (63)
Approvals (5694)
Artificial intelligence (80)
Bankruptcy (99)
Best Places to Work (4545)
Biotechnology (249)
Breast cancer (121)
Cancer (996)
Cardiovascular disease (83)
Career advice (132)
CAR-T (82)
Cell therapy (239)
Clinical research (40389)
Collaboration (373)
Compensation (152)
COVID-19 (1014)
C-suite (98)
Cystic fibrosis (69)
Data (1044)
Diabetes (92)
Diagnostics (1214)
Earnings (29081)
Events (47401)
Executive appointments (295)
FDA (6130)
Funding (358)
Gene editing (70)
Gene therapy (179)
GLP-1 (325)
Government (1088)
Healthcare (6565)
Infectious disease (1055)
Inflammatory bowel disease (100)
IPO (7225)
Job creations (861)
Job search strategy (127)
Layoffs (192)
Legal (1387)
Lung cancer (144)
Lymphoma (63)
Manufacturing (91)
Medical device (2565)
Medtech (2566)
Mergers & acquisitions (6182)
Metabolic disorders (283)
Neuroscience (1056)
NextGen: Class of 2025 (2014)
Non-profit (852)
Northern California (1196)
Obesity (154)
Opinion (93)
Parkinson's disease (82)
Patents (69)
People (25241)
Phase I (14232)
Phase II (18764)
Phase III (11905)
Pipeline (445)
Postmarket research (860)
Preclinical (5980)
Radiopharmaceuticals (207)
Rare diseases (219)
Real estate (1416)
Regulatory (8395)
Research institute (932)
Series A (71)
Southern California (1074)
Startups (1968)
United States (9469)
Vaccines (175)
Weight loss (91)
Date
Today (12)
Last 7 days (245)
Last 30 days (1108)
Last 365 days (20424)
2025 (971)
2024 (20595)
2023 (22430)
2022 (26853)
2021 (27844)
2020 (23390)
2019 (16267)
2018 (11762)
2017 (13759)
2016 (11855)
2015 (14366)
2014 (10405)
2013 (7498)
2012 (7558)
2011 (7631)
2010 (7442)
Location
Africa (146)
Asia (17025)
Australia (2887)
California (2722)
Canada (867)
China (247)
Colorado (101)
Connecticut (116)
Europe (36657)
Florida (303)
Georgia (78)
Illinois (170)
Indiana (66)
Maryland (361)
Massachusetts (2164)
Minnesota (111)
New Jersey (672)
New York (747)
North Carolina (442)
Northern California (1196)
Ohio (87)
Pennsylvania (521)
South America (208)
Southern California (1074)
Texas (304)
Washington State (266)
263,204 Results for "rani therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”)(Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a definitive agreement with ProGen Co., Ltd.
June 24, 2024
·
7 min read
Press Releases
Rani Therapeutics to Participate in Upcoming Investor Conferences
November 8, 2024
·
1 min read
Business
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the quarter ended March 31, 2024 and provided a corporate update.
May 6, 2024
·
7 min read
Biotech Bay
Rani Therapeutics to Participate in May 2024 Investor Conferences
Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, announced that the Company will participate in two upcoming investor conferences in May 2024.
May 14, 2024
·
1 min read
Press Releases
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
November 14, 2024
·
8 min read
News
Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
October 8, 2024
·
1 min read
Business
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the quarter and full year ended December 31, 2023 and provided a corporate update.
March 20, 2024
·
11 min read
Business
Rani Therapeutics to Participate in September Investor Conferences
September 3, 2024
·
1 min read
Press Releases
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
October 17, 2024
·
6 min read
Business
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
Rani Therapeutics Holdings, Inc. today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2023 and provide a business update on Wednesday, March 20 after the close of trading.
March 15, 2024
·
1 min read
1 of 26,321
Next
